Published in Clin Epigenetics on May 27, 2016
Developing EZH2-Targeted Therapy for Lung Cancer. Cancer Discov (2016) 0.75
STAT5-Interacting Proteins: A Synopsis of Proteins that Regulate STAT5 Activity. Biology (Basel) (2017) 0.75
Chromatin Switches during Neural Cell Differentiation and Their Dysregulation by Prenatal Alcohol Exposure. Genes (Basel) (2017) 0.75
Renal Medullary Carcinoma: Establishing Standards in Practice. J Oncol Pract (2017) 0.75
A gene complex controlling segmentation in Drosophila. Nature (1978) 23.75
A landscape of driver mutations in melanoma. Cell (2012) 12.61
The Polycomb complex PRC2 and its mark in life. Nature (2011) 11.97
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet (2010) 10.97
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J (2003) 9.55
Role of the polycomb protein EED in the propagation of repressive histone marks. Nature (2009) 6.62
Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol Cell (2004) 5.06
Jarid2 and PRC2, partners in regulating gene expression. Genes Dev (2010) 4.65
Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc Natl Acad Sci U S A (2005) 4.57
Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas. Proc Natl Acad Sci U S A (2010) 4.52
The protein encoded by the Drosophila position-effect variegation suppressor gene Su(var)3-9 combines domains of antagonistic regulators of homeotic gene complexes. EMBO J (1994) 4.36
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol (2005) 4.24
Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27). Proc Natl Acad Sci U S A (2012) 3.22
Cold-induced silencing by long antisense transcripts of an Arabidopsis Polycomb target. Nature (2009) 2.97
Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo. Mol Cell Biol (2008) 2.93
Interaction of Polycomb-group proteins controlling flowering in Arabidopsis. Development (2004) 2.87
Is there a code embedded in proteins that is based on post-translational modifications? Nat Rev Mol Cell Biol (2008) 2.64
Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators. Nat Cell Biol (2010) 2.55
Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell (2013) 2.38
Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes. Nucleic Acids Res (2010) 2.37
CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat Cell Biol (2010) 2.36
Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers. Mol Cell (2011) 2.12
Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog (2008) 2.01
Structural basis of histone H4 recognition by p55. Genes Dev (2008) 1.95
Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies. Leukemia (2013) 1.84
AEBP2 as a potential targeting protein for Polycomb Repression Complex PRC2. Nucleic Acids Res (2009) 1.79
Polycomb Group proteins: an evolutionary perspective. Trends Genet (2007) 1.79
A new overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly. J Pediatr (1974) 1.73
Polycomb-dependent epigenetic landscape in adult T-cell leukemia. Blood (2016) 1.46
Interaction of Vav with ENX-1, a putative transcriptional regulator of homeobox gene expression. Mol Cell Biol (1996) 1.34
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes. Mol Oncol (2012) 1.24
EZH2: not EZHY (easy) to deal. Mol Cancer Res (2014) 1.20
Transcriptional silencing by polycomb-group proteins. Cold Spring Harb Perspect Biol (2014) 1.19
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors. Nat Commun (2015) 1.15
Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nat Immunol (2015) 1.14
Polycomb proteins in mammalian cell differentiation and plasticity. FEBS Lett (2011) 1.12
Origin of the polycomb repressive complex 2 and gene silencing by an E(z) homolog in the unicellular alga Chlamydomonas. Epigenetics (2010) 1.12
SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2. Nat Med (2015) 1.10
Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation. PLoS Genet (2014) 1.09
Dosage compensation in mammals. Cold Spring Harb Perspect Biol (2015) 1.07
A687V EZH2 is a gain-of-function mutation found in lymphoma patients. FEBS Lett (2012) 1.06
Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype. Am J Med Genet A (2013) 1.04
Triple negative breast cancer: looking for the missing link between biology and treatments. Oncotarget (2015) 1.03
EZH2, an epigenetic driver of prostate cancer. Protein Cell (2013) 1.02
IKKα restoration via EZH2 suppression induces nasopharyngeal carcinoma differentiation. Nat Commun (2014) 1.00
Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31. Cell Death Dis (2014) 0.98
Product binding enforces the genomic specificity of a yeast polycomb repressive complex. Cell (2014) 0.97
Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma. Blood (2012) 0.96
Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target. Oncotarget (2016) 0.94
Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer. Cancer Cell (2016) 0.94
YY1 controls Igκ repertoire and B-cell development, and localizes with condensin on the Igκ locus. EMBO J (2013) 0.94
Impaired PRC2 activity promotes transcriptional instability and favors breast tumorigenesis. Genes Dev (2015) 0.93
IKK1 control of epidermal differentiation is modulated by notch signaling. Am J Pathol (2011) 0.93
High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer. Int J Oncol (2013) 0.93
Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer. Oncotarget (2016) 0.92
Epigenetic regulation in plant responses to the environment. Cold Spring Harb Perspect Biol (2014) 0.90
Neural crest stem cells in melanoma development. Curr Opin Oncol (2014) 0.90
Regulation of the X chromosomes in Caenorhabditis elegans. Cold Spring Harb Perspect Biol (2014) 0.89
Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner. Blood (2015) 0.88
The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers. Mol Carcinog (2014) 0.87
EZH2 Inhibition Blocks Multiple Myeloma Cell Growth through Upregulation of Epithelial Tumor Suppressor Genes. Mol Cancer Ther (2015) 0.86
Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance. Expert Opin Drug Metab Toxicol (2014) 0.86
Functional characterization of EZH2β reveals the increased complexity of EZH2 isoforms involved in the regulation of mammalian gene expression. Epigenetics Chromatin (2013) 0.84
Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations. Cancer Res (2015) 0.84
Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma. J Pathol (2016) 0.80
Ezh2 regulates the Lin28/let-7 pathway to restrict activation of fetal gene signature in adult hematopoietic stem cells. Exp Hematol (2016) 0.77
The association between Hirschsprung's disease and multiple endocrine neoplasia type 2a: a systematic review. Pediatr Surg Int (2014) 0.77
Possible prognostic value of BORIS transcript variants ratio in laryngeal squamous cell carcinomas - a pilot study. Pathol Oncol Res (2014) 0.76